Home/Filings/4/0001055726-18-000049
4//SEC Filing

DHILLON AVTAR S 4

Accession 0001055726-18-000049

CIK 0001055726other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 5:17 PM ET

Size

7.1 KB

Accession

0001055726-18-000049

Insider Transaction Report

Form 4
Period: 2018-12-06
DHILLON AVTAR S
DirectorExecutive Chairman
Transactions
  • Exercise/Conversion

    Common Stock

    2018-12-06$2.00/sh+25,000$50,000106,002 total
  • Exercise/Conversion

    Common Stock Options

    2018-12-0625,0000 total
    Exercise: $2.00From: 2008-12-09Exp: 2018-12-09Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
  • [F2]The shares underlying this option vested and became exercisable on various dates between December 9, 2008 and December 9, 2011.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001260933

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:17 PM ET
Size
7.1 KB